Lion T. Adenovirus Infections in Immunocompetent and Immunocompromised Patients. Clin Microbiol Rev. 2014; 27: 441–462. https://doi.org/10.1128/CMR.00116-13 PMID: 24982316
Seto D, Chodosh J, Brister JR, Jones MS. Using the Whole-Genome Sequence To Characterize and Name Human Adenoviruses!. J Virol. 2011; 85: 5701–5702. https://doi.org/10.1128/JVI.00354-11 PMID: 21450823
Lynch J, Kajon A. Adenovirus: Epidemiology, Global Spread of Novel Serotypes, and Advances in Treatment and Prevention. Semin Respir Crit Care Med. 2016; 37: 586–602. https://doi.org/10.1055/s-0036-1584923 PMID: 27486739
Pecori R, Di Giorgio S, Paulo Lorenzo J, Nina Papavasiliou F. Functions and consequences of AID/ APOBEC-mediated DNA and RNA deamination. Nat Rev Genet. 2022. https://doi.org/10.1038/s41576-022-00459-8 PMID: 35256818
Xu WK, Byun H, Dudley JP. The Role of APOBECs in Viral Replication. Microorganisms. 2020;8. https://doi.org/10.3390/microorganisms8121899 PMID: 33266042
Bandarra S, Miyagi E, Ribeiro AC, Gonçalves J, Strebel K, Barahona I. APOBEC3B potently restricts HIV-2 but not HIV-1 in a Vif-dependent manner. J Virol. 2021; JVI0117021. https://doi.org/10.1128/JVI. 01170-21 PMID: 34523960
Doehle BP, Schäfer A, Cullen BR. Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif. Virology. 2005; 339: 281–288. https://doi.org/10.1016/j.virol.2005.06.005 PMID: 15993456
Ooms M, Krikoni A, Kress AK, Simon V, Münk C. APOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1. J Virol. 2012; 86: 6097–6108. https://doi.org/10.1128/JVI.06570-11 PMID: 22457529
Suspène R, Guétard D, Henry M, Sommer P, Wain-Hobson S, Vartanian J-P. Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo. Proc Natl Acad Sci. 2005; 102: 8321–8326. https://doi.org/10.1073/pnas.0408223102 PMID: 15919829
Bogerd HP, Wiegand HL, Doehle BP, Lueders KK, Cullen BR. APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells. Nucleic Acids Res. 2006; 34: 89–95. https://doi.org/10.1093/nar/gkj416 PMID: 16407327
Wissing S, Montano M, Garcia-Perez JL, Moran JV, Greene WC. Endogenous APOBEC3B restricts LINE-1 retrotransposition in transformed cells and human embryonic stem cells. J Biol Chem. 2011; 286: 36427–36437. https://doi.org/10.1074/jbc.M111.251058 PMID: 21878639
Cheng AZ, Yockteng-Melgar J, Jarvis MC, Malik-Soni N, Borozan I, Carpenter MA, et al. Epstein–Barr virus BORF2 inhibits cellular APOBEC3B to preserve viral genome integrity. Nat Microbiol. 2019; 4: 78. https://doi.org/10.1038/s41564-018-0284-6 PMID: 30420783
Cheng AZ, Moraes SN, Attarian C, Yockteng-Melgar J, Jarvis MC, Biolatti M, et al. A Conserved Mechanism of APOBEC3 Relocalization by Herpesviral Ribonucleotide Reductase Large Subunits. J Virol. 93: e01539–19. https://doi.org/10.1128/JVI.01539-19 PMID: 31534038
Mori S, Takeuchi T, Ishii Y, Yugawa T, Kiyono T, Nishina H, et al. Human Papillomavirus 16 E6 Upregulates APOBEC3B via the TEAD Transcription Factor. J Virol. 2017;91. https://doi.org/10.1128/JVI. 02413-16 PMID: 28077648
Starrett GJ, Serebrenik AA, Roelofs PA, McCann JL, Verhalen B, Jarvis MC, et al. Polyomavirus T Antigen Induces APOBEC3B Expression Using an LXCXE-Dependent and TP53-Independent Mechanism. mBio. 2019;10. https://doi.org/10.1128/mBio.02690-18 PMID: 30723127
Verhalen B, Starrett GJ, Harris RS, Jiang M. Functional Upregulation of the DNA Cytosine Deaminase APOBEC3B by Polyomaviruses. J Virol. 2016; 90: 6379–6386. https://doi.org/10.1128/JVI.00771-16 PMID: 27147740
Vieira VC, Leonard B, White EA, Starrett GJ, Temiz NA, Lorenz LD, et al. Human Papillomavirus E6 Triggers Upregulation of the Antiviral and Cancer Genomic DNA Deaminase APOBEC3B. mBio. 2014; 5: e02234–14. https://doi.org/10.1128/mBio.02234-14 PMID: 25538195
Peretti A, Geoghegan EM, Pastrana DV, Smola S, Feld P, Sauter M, et al. Characterization of BK Polyomaviruses from Kidney Transplant Recipients Suggests a Role for APOBEC3 in Driving In-Host Virus Evolution. Cell Host Microbe. 2018; 23: 628–635.e7. https://doi.org/10.1016/j.chom.2018.04.005 PMID: 29746834
Warren CJ, Van Doorslaer K, Pandey A, Espinosa JM, Pyeon D. Role of the host restriction factor APOBEC3 on papillomavirus evolution. Virus Evol. 2015;1. https://doi.org/10.1093/ve/vev015 PMID: 27570633
Poulain F, Lejeune N, Willemart K, Gillet NA. Footprint of the host restriction factors APOBEC3 on the genome of human viruses. PLOS Pathog. 2020; 16: e1008718. https://doi.org/10.1371/journal.ppat. 1008718 PMID: 32797103
Lejeune N, Poulain F, Willemart K, Blockx Z, Mathieu S, Gillet NA. Infection of bronchial epithelial cells by the human adenoviruses A12, B3 and C2 differently regulates the innate antiviral effector APOBEC3B. J Virol. 2021. https://doi.org/10.1128/JVI.02413-20 PMID: 33853956
Ibelgaufts H, Doerfler W, Scheidtmann KH, Wechsler W. Adenovirus type 12-induced rat tumor cells of neuroepithelial origin: persistence and expression of the viral genome. J Virol. 1980; 33: 423–437. https://doi.org/10.1128/JVI.33.1.423-437.1980 PMID: 7365869
Kuhlmann I, Achten S, Rudolph R, Doerfler W. Tumor induction by human adenovirus type 12 in hamsters: loss of the viral genome from adenovirus type 12-induced tumor cells is compatible with tumor formation. EMBO J. 1982; 1: 79–86. https://doi.org/10.1002/j.1460-2075.1982.tb01128.x PMID: 7188179
Hohlweg U, Dorn A, Hösel M, Webb D, Buettner R, Doerfler W. Tumorigenesis by Adenovirus Type 12 in Newborn Syrian Hamsters. In: Doerfler W, Böhm P, editors. Adenoviruses: Model and Vectors in Virus-Host Interactions. Berlin, Heidelberg: Springer Berlin Heidelberg; 2004. pp. 215–244. https://doi.org/10.1007/978-3-662-05599-1_7
Cheng CY, Gilson T, Dallaire F, Ketner G, Branton PE, Blanchette P. The E4orf6/E1B55K E3 ubiquitin ligase complexes of human adenoviruses exhibit heterogeneity in composition and substrate specificity. J Virol. 2011; 85: 765–775. https://doi.org/10.1128/JVI.01890-10 PMID: 21068234
Scholtés GK, Sawyer AM, Vaca CC, Clerc I, Roh M, Song C, et al. The von Hippel–Lindau Cullin-RING E3 ubiquitin ligase regulates APOBEC3 cytidine deaminases. Transl Res. 2021; 237: 1–15. https://doi.org/10.1016/j.trsl.2021.05.002 PMID: 34004371
Matsumoto T, Shirakawa K, Yokoyama M, Fukuda H, Sarca AD, Koyabu S, et al. Protein kinase A inhibits tumor mutator APOBEC3B through phosphorylation. Sci Rep. 2019; 9: 8307. https://doi.org/10.1038/s41598-019-44407-9 PMID: 31165764
King CR, Cohen MJ, Fonseca GJ, Dirk BS, Dikeakos JD, Mymryk JS. Functional and Structural Mimicry of Cellular Protein Kinase A Anchoring Proteins by a Viral Oncoprotein. PLOS Pathog. 2016; 12: e1005621. https://doi.org/10.1371/journal.ppat.1005621 PMID: 27137912
Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SAJR, Behjati S, Biankin AV, et al. Signatures of mutational processes in human cancer. Nature. 2013; 500: 415–421. https://doi.org/10.1038/ nature12477 PMID: 23945592
Burns MB, Lackey L, Carpenter MA, Rathore A, Land AM, Leonard B, et al. APOBEC3B is an enzymatic source of mutation in breast cancer. Nature. 2013; 494: 366–370. https://doi.org/10.1038/nature11881 PMID: 23389445
Burns MB, Temiz NA, Harris RS. Evidence for APOBEC3B mutagenesis in multiple human cancers. Nat Genet. 2013; 45: 977–983. https://doi.org/10.1038/ng.2701 PMID: 23852168
de Bruin EC, McGranahan N, Mitter R, Salm M, Wedge DC, Yates L, et al. Spatial and temporal diversity in genomic instability processes defines lung cancer evolution. Science. 2014; 346: 251–256. https://doi.org/10.1126/science.1253462 PMID: 25301630
Mayekar MK, Caswell DR, Vokes NI, Law EK, Wu W, Hill W, et al. Targeted cancer therapy induces APOBEC fuelling the evolution of drug resistance. 2020 Dec p. 2020.12.18.423280. https://doi.org/10.1101/2020.12.18.423280
Venkatesan S, Angelova M, Puttick C, Zhai H, Caswell DR, Lu W-T, et al. Induction of APOBEC3 Exacerbates DNA Replication Stress and Chromosomal Instability in Early Breast and Lung Cancer Evolution. Cancer Discov. 2021; 11: 2456–2473. https://doi.org/10.1158/2159-8290.CD-20-0725 PMID: 33947663
Huff AL, Wongthida P, Kottke T, Thompson JM, Driscoll CB, Schuelke M, et al. APOBEC3 Mediates Resistance to Oncolytic Viral Therapy. Mol Ther—Oncolytics. 2018; 11: 1–13. https://doi.org/10.1016/j.omto.2018.08.003 PMID: 30294666
Kim E-Y, Bhattacharya T, Kunstman K, Swantek P, Koning FA, Malim MH, et al. Human APOBEC3Gmediated editing can promote HIV-1 sequence diversification and accelerate adaptation to selective pressure. J Virol. 2010; 84: 10402–10405. https://doi.org/10.1128/JVI.01223-10 PMID: 20660203
Taylor BJ, Nik-Zainal S, Wu YL, Stebbings LA, Raine K, Campbell PJ, et al. DNA deaminases induce break-associated mutation showers with implication of APOBEC3B and 3A in breast cancer kataegis. eLife. 2013; 2: e00534. https://doi.org/10.7554/eLife.00534 PMID: 23599896
Henderson S, Chakravarthy A, Su X, Boshoff C, Fenton TR. APOBEC-mediated cytosine deamination links PIK3CA helical domain mutations to human papillomavirus-driven tumor development. Cell Rep. 2014; 7: 1833–1841. https://doi.org/10.1016/j.celrep.2014.05.012 PMID: 24910434
Alexandrov LB, Kim J, Haradhvala NJ, Huang MN, Tian Ng AW, Wu Y, et al. The repertoire of mutational signatures in human cancer. Nature. 2020; 578: 94–101. https://doi.org/10.1038/s41586-020-1943-3 PMID: 32025018
Chan K, Roberts SA, Klimczak LJ, Sterling JF, Saini N, Malc EP, et al. An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers. Nat Genet. 2015; 47: 1067–1072. https://doi.org/10.1038/ng.3378 PMID: 26258849
Law EK, Levin-Klein R, Jarvis MC, Kim H, Argyris PP, Carpenter MA, et al. APOBEC3A catalyzes mutation and drives carcinogenesis in vivo. J Exp Med. 2020;217. https://doi.org/10.1084/jem.20200261 PMID: 32870257
Wallace NA, Münger K. The curious case of APOBEC3 activation by cancer-associated human papillomaviruses. PLOS Pathog. 2018; 14: e1006717. https://doi.org/10.1371/journal.ppat.1006717 PMID: 29324878
Baker SC, Mason AS, Slip RG, Skinner KT, Macdonald A, Masood O, et al. Induction of APOBEC3-mediated genomic damage in urothelium implicates BK polyomavirus (BKPyV) as a hit-and-run driver for bladder cancer. Oncogene. 2022. https://doi.org/10.1038/s41388-022-02235-8 PMID: 35194151
Ramirez RD, Sheridan S, Girard L, Sato M, Kim Y, Pollack J, et al. Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins. Cancer Res. 2004; 64: 9027–9034. https://doi.org/10.1158/0008-5472.CAN-04-3703 PMID: 15604268
Law EK, Sieuwerts AM, LaPara K, Leonard B, Starrett GJ, Molan AM, et al. The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer. Sci Adv. 2016;2. https://doi.org/10.1126/sciadv.1601737 PMID: 27730215
Huang C, Kolokoltsova OA, Mateer EJ, Koma T, Paessler S. Highly Pathogenic New World Arenavirus Infection Activates the Pattern Recognition Receptor Protein Kinase R without Attenuating Virus Replication in Human Cells. J Virol. 2017; 91: e01090–17. https://doi.org/10.1128/JVI.01090-17 PMID: 28794024
Wang S-L, Chi C-Y, Kuo P-H, Tsai H-P, Wang S-M, Liu C-C, et al. High-Incidence of Human Adenoviral Co-Infections in Taiwan. PLoS ONE. 2013;8. https://doi.org/10.1371/journal.pone.0075208 PMID: 24073254
Refsland EW, Stenglein MD, Shindo K, Albin JS, Brown WL, Harris RS. Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction. Nucleic Acids Res. 2010; 38: 4274–4284. https://doi.org/10.1093/nar/gkq174 PMID: 20308164
Leonard B, McCann JL, Starrett GJ, Kosyakovsky L, Luengas EM, Molan AM, et al. The PKC/NF-κB signaling pathway induces APOBEC3B expression in multiple human cancers. Cancer Res. 2015; 75: 4538–4547. https://doi.org/10.1158/0008-5472.CAN-15-2171-T PMID: 26420215
Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012; 9: 671–675. https://doi.org/10.1038/nmeth.2089 PMID: 22930834
Suspène R, Henry M, Guillot S, Wain-Hobson S, Vartanian J-P. Recovery of APOBEC3-edited human immunodeficiency virus G->A hypermutants by differential DNA denaturation PCR. J Gen Virol. 2005; 86: 125–129. https://doi.org/10.1099/vir.0.80426–0
Suspène R, Aynaud M-M, Guétard D, Henry M, Eckhoff G, Marchio A, et al. Somatic hypermutation of human mitochondrial and nuclear DNA by APOBEC3 cytidine deaminases, a pathway for DNA catabolism. Proc Natl Acad Sci. 2011; 108: 4858–4863. https://doi.org/10.1073/pnas.1009687108 PMID: 21368204
Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012; 9: 676–682. https://doi.org/10.1038/nmeth. 2019 PMID: 22743772
Manders EMM, Verbeek FJ, Aten JA. Measurement of co-localization of objects in dual-colour confocal images. J Microsc. 1993; 169: 375–382. https://doi.org/10.1111/j.1365-2818.1993.tb03313.x PMID: 33930978
